lumicell.comHealthcare / Other HealthcareFounded: 2009Funding to Date: $466.36MM
Lumicell is a provider image-guided cancer surgery, offering technology that illuminates cancer cells in the tumor cavity, enabling physicians to take action in real time to improve patient outcomes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/22/2024 | Series D-4 | $10.87MM | $xx.xx | $315.24MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
468,033
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
02/22/2024 | Series D-3 | $10.87MM | $xx.xx | $315.24MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
468,033
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
07/14/2023 | Series D-2 | $21.68MM | $xx.xx | $316.12MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
933,122
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
07/14/2023 | Series D-1 | $54.17MM | $xx.xx | $316.12MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,914,785
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
12/07/2018 | Series D | $27.65MM | $xx.xx | $278.48MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,190,222
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
07/12/2017 | Series C | $29.44MM | $xx.xx | $107.26MM | Launch Capital, BlueIO | |
Price per Share
$xx.xx
Shares Outstanding
1,979,079
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Launch Capital, BlueIO
|
||||||
12/19/2013 | Series B | $2.82MM | $xx.xx | $27.42MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
418,603
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
05/18/2011 | Series A | $3.93MM | $xx.xx | $13.11MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,207,322
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|